Bilcare Ltd.

NSE: BI · Healthcare Research, Analytics & Technology · sector

₹80.20NSE close 2026-10-26

Key numbers

Market cap₹189 cr

Price₹80.20

52w high / low₹113 / ₹52

P/E4.3xSector median 27.9x

P/B1.0xSector median 3.0x

Book value₹83.5

Dividend yield–Sector median 0.34%

ROE2.3%Sector median 6.1%

ROCE7.0%Sector median 9.8%

OPM8.4%Sector median 8.4%

Debt / equity3.15xSector median 0.01x

EV/EBITDA12.4xSector median 14.8x

Interest cover0.8x

Current ratio0.99x

Sales growth 3y+274.4%Sector median +7.2%

Profit growth 3y-83.3%Sector median -13.6%

PEG–

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 9 companies in Healthcare Research, Analytics & Technology (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹6 cr vs borrowings ₹620 cr (FY26): borrowings are higher by ₹615 cr.
Operating profit covered interest 0.8x in the last 12 months.
Net loss in 3 of the last 6 quarters.
Other income was 331% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹80.20 on 2026-10-26: -29.0% from the 52-week high, +55.4% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹112.45 · low ₹53.62

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	194	186	178	181	188	226
EBITDA	21	11	3	11	15	35
OPM %	10.9%	5.9%	1.9%	6.2%	8.0%	15.6%
Other income	7	6	4	5	14	2
Net profit	11	-4	-12	-6	13	13
EPS (₹)	4.48	1.59	5.25	2.53	5.68	5.39
Revenue YoY					-3.3%	+21.2%
Profit YoY					+26.6%	–

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	430	14	18	788	734	773
EBITDA	64	506	2	39	41	65
Net profit	-18	367	5	-29	2	8
EPS (₹)	-7.55	165.98	2.27	12.22	0.73	18.85
Revenue growth		-96.7%	+25.9%	+4,377.5%	-6.9%	–
Profit growth		–	-98.5%	-639.0%	–	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+274.4%	–	–
Net profit	-83.3%	–	–
EPS	-83.6%	–	–
Share price	–	– (2y)	–

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	469	197
Borrowings	682	620
Cash & equivalents	15	6
Total assets	1,417	843
Fixed assets	933	425
Capital work in progress	3	8
Investments	11	14
Receivables	119	108
Inventory	117	115
Payables	84	94

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	85	128
Cash from investing	81	-6
Cash from financing	-169	-132
Capex	23	11
Free cash flow	62	117

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	-6.1%	0.9%
ROCE %	1.0%	6.2%
Debtor days	55	54
Inventory days	80	86
Payable days	57	70
Cash conversion cycle (days)	78	70
Working capital days	-28	-1

Peers in Healthcare Research, Analytics & Technology

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SYNGENE	₹14,527 cr	65.4x	3.0x	4.6%	7.0%	19.8%	+5.4%	0.35%
INDGN	₹14,472 cr	36.0x	4.6x	13.9%	17.4%	16.2%	–	0.33%
SUVEN	₹6,917 cr	–	11.7x	-100.5%	-59.5%	-4,155.5%	-19.3%	–
VIMTALABS	₹2,185 cr	27.4x	4.8x	19.1%	23.5%	34.3%	+8.9%	0.20%
BI	₹189 cr	4.3x	1.0x	2.3%	7.0%	8.4%	+274.4%	–
TAKE	₹154 cr	12.1x	5.0x	49.8%	20.1%	-2.0%	-34.1%	–
NOVELIX	₹141 cr	31.7x	3.0x	11.3%	8.8%	3.1%	+411.3%	–
JSTL	₹102 cr	28.5x	1.4x	6.1%	9.8%	20.5%	+19.4%	0.97%
ADESHWAR	₹23 cr	18.0x	0.9x	5.5%	10.2%	4.9%	-12.0%	–

All 9 companies in Healthcare Research, Analytics & Technology →

Dividends & corporate actions

Ex-date	Action	Detail
2012-09-20	Dividend	Dividend Rs 2.0
2011-09-20	Dividend	Dividend Rs 3.0
2010-09-23	Dividend	Dividend Rs 2.5
2009-09-17	Dividend	Dividend Rs 2.5
2007-09-20	Dividend	Dividend Rs 4.0

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Healthcare Research, Analytics & Technology
Sub-industry	Healthcare Research, Analytics & Technology
Symbol	BI
BSE code	526853
ISIN	INE986A01012
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = NSE close 2026-10-26.